This from the In the Pipeline blog quoting Peter Corr, former Pfizer head of global development. "Big Pharma should get smaller." That's an $8 billion dollar education speaking for the school of hard knocks.
Corr further expands on this, "We needed .....[to] keep smaller R&D sites and let them go on their own. Let them be funded independently. Let them define how they can work best at their particular site as opposed to manage all of these sites around the world and pretend that we knew what was actually going on."
In other words, Pfizer should have followed this Elizabethan business model for pharma:
Posted by Bruce Lehr April 25th 2011.